Call Now

Prostatic Hyperplasia (PH)

BPH; BEP; BPE; Benign enlargement of the prostate

Benign prostatic hyperplasia (BPH), is a noncancerous increase in size of the prostate. BPH involves hyperplasia of prostatic stromal and epithelial cells, resulting in the formation of large, fairly discrete nodules in the transition zone of the prostate. BPH involves hyperplasia (an increase in the number of cells) rather than hypertrophy (a growth in the size of individual cells), but the two terms are often used interchangeably, even among urologists. When sufficiently large, the nodules push on and narrow the urethra resulting in an increased resistance to flow of urine from the bladder. This is commonly referred to as "obstruction", although the urethral lumen is no less patent, only compressed.

Organism species: Pan-species (General)

Proteins N/A Recombinant Prostatic Hyperplasia (PH) Antigenic Transformation Customized Service Offer
Antibodies N/A Monoclonal Antibody to Prostatic Hyperplasia (PH) Monoclonal Antibody Customized Service Offer
N/A Polyclonal Antibody to Prostatic Hyperplasia (PH) Polyclonal Antibody Customized Service Offer
Assay Kits N/A CLIA Kit for Prostatic Hyperplasia (PH) CLIA Kit Customized Service Offer
N/A ELISA Kit for Prostatic Hyperplasia (PH) ELISA Kit Customized Service Offer